Abstract
DNA methylation has emerged as a potentially robust biomarker for prostate cancer (PCa). Since DNA methylomes appear to be disease as well as population specific, we have assessed the DNA methylation status of RASSF1A, APC, and p16 (potential biomarkers of PCa) in Pakistani population. Primary prostate cancer tissues were obtained from 27 formalin-fixed paraffin-embedded blocks (FFPE) of cancer patients who underwent radical prostatectomy and transurethral resection of prostate (TURP) during 2003–2008. As controls, twenty-four benign prostatic FFPE tissues were obtained from patients who underwent TURP for benign prostatic hyperplasia during 2008. DNA was extracted, and methylation-specific PCR was used to assess the methylation status for RASSF1A, APC, and p16 gene promoters. Our results revealed that the RASSF1A promoter was hypermethylated in all the tested cancer samples but was also hypermethylated in 3 out of 24 control tissues. The APC promoter was hypermethylated in 15 out of 27 cancer samples and in none of the control samples. Strikingly, none of the samples showed methylation at the p16 promoter. Our findings suggest that RASSF1A and APC gene promoters are frequently hypermethylated in the Pakistani population and therefore have the potential to develop into universally dependable biomarkers for detecting PCa.
Highlights
A well-characterized epigenetic mechanism is DNA methylation
Prostate cancer tissues were obtained from 18 paraffin-embedded blocks of cancer patients who underwent radical prostatectomy and 9 patients who underwent transurethral resection of prostate (TURP) during 2003–2008; blocks with >70% cancerous tissue were selected a er histological examination of slides
Our results show that RASSF1A was hypermethylated in all 27 prostate cancer tissues
Summary
A well-characterized epigenetic mechanism is DNA methylation. DNA methylation typically occurs at CpG islands that are located in the promoter regions of about 50% of human genes. A number of gene promoters including GSTP1, APC, RASSSF1A, COX2, MDR1, ERαα, hMLH1, and p14/INK have been found to be frequently hypermethylated in PCa [9,10,11,12]. Accumulating data on the methylation status of various genes indicates that biomarkers based on speci c methylomes may serve to differentiate between cancerous and non-cancerous prostate tissues [9, 12,13,14]. An example of this phenomenon is illustrated by the difference in the relationship between methylation status of p16 gene in Japanese population versus Caucasian population (hypermethylation in Japanese and hypomethylation in Caucasians [10, 12]). We assessed the DNA methylation status of APC and RASSF1A (hypermethylated in all populations) and p16 (variable methylation status) in Pakistani PCa patients
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
